Question of the Day – Thursday July 26, 2018

Question - Ceftriaxone is a third-generation cephalosporin with broad spectrum activity against both Gram-negative and Gram-positive bacteria. What potential toxicities have limited the use of this drug in neonatal patients?

Read More...

Question of the Day – Wednesday July 25, 2018

Question - What characterizes cutaneous reactions to bed bug (Cimex lectularius) bites?

Read More...

Question of the Day – Tuesday July 24, 2018

Question - Inhalational anthrax is a rare disease that can occur after exposure to infected animals or contaminated animal products, or as a result of an intentional release of anthrax spores. It is caused by breathing in the spores of the bacterium Bacillus anthracis. When inhaled, the anthrax bacteria replicate in the body and produce toxins that can cause massive and irreversible tissue injury and death. Anthrax is a potential bioterrorism threat because the spores are resistant to destruction and can be spread by release in the air. What drug has recently been approved as a new treatment for inhalation anthrax?

Read More...

Question of the Day – Monday July 23, 2018

Question - The U.S. Food and Drug Administration recently warned about contamination with brodifacoum of which illegal, often abused, substances?

Read More...

Question of the Day – Friday July 20, 2018

Question - In what industries might workers become exposed to dangerous levels of hydrogen sulfide?

Read More...

Question of the Day – Thursday July 19, 2018

Question - Workers at a lamp recycling facility may be at risk for the development of toxicity from what metal?

Read More...

Question of the Day – Wednesday July 18, 2018

Question - What potentially catastrophic adverse effect has been associated with the administration of fluoroquinolones in persons over the age of 65 years.

Read More...

Question of the Day – Tuesday July 17, 2018

Question - Since its resurgence as a drug used in the treatment of some cases severe sepsis reports of extravasation and skin necrosis due to vasopressin have appeared in the literature. What is the recommended treatment for vasopressin extravasation?

Read More...

Question of the Day – Monday July 16, 2018

Question - Cisplatin is an antineoplastic drug that may be used in the treatment of a variety of solid organ cancers. What is the primary does-limiting toxicity associated with the use of this drug?

Read More...

Question of the Day – Friday July 13, 2018

Question - What are the goals of the NIOSH Health Hazard Evaluation (HHE) program?

Read More...

Site Search